These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 7524160)

  • 1. Factor VIII inhibitors: structure and function in autoantibody and hemophilia A patients.
    Hoyer LW; Scandella D
    Semin Hematol; 1994 Apr; 31(2 Suppl 4):1-5. PubMed ID: 7524160
    [No Abstract]   [Full Text] [Related]  

  • 2. [Factor VIII epitopes recognized by inhibitors in hemophiliacs].
    Hayashi T; Niiya K; Sakuragawa N; Ichihara K; Yamazaki T; Watanabe A
    Rinsho Ketsueki; 1991 Sep; 32(9):945-50. PubMed ID: 1719257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of factor VIII versus nonspecific inhibitors.
    Goldsmith JC
    Semin Hematol; 1993 Apr; 30(2 Suppl 1):3-6. PubMed ID: 8480195
    [No Abstract]   [Full Text] [Related]  

  • 4. Evidence for antiphospholipid antibodies in hemophilic children with factor VIII inhibitors. Recombinate PUP Study Group.
    Nuss R; Jacobson L; Hathaway WE; Manco-Johnson M
    Thromb Haemost; 1999 Nov; 82(5):1559-60. PubMed ID: 10595659
    [No Abstract]   [Full Text] [Related]  

  • 5. The treatment of acquired factor VIII inhibitors: worldwide experience with porcine factor VIII concentrate. International Acquired Hemophilia Study Group.
    Kessler CM; Ludlam CA
    Semin Hematol; 1993 Apr; 30(2 Suppl 1):22-7. PubMed ID: 8480193
    [No Abstract]   [Full Text] [Related]  

  • 6. World registry on factor VIII inhibitor patients: why?
    Aledort LM
    Semin Hematol; 1993 Apr; 30(2 Suppl 1):7-9. PubMed ID: 8480198
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibitor to factor VIII in mild haemophilia.
    Kesteven PJ; Holland LJ; Lawrie AS; Savidge GF
    Thromb Haemost; 1984 Aug; 52(1):50-2. PubMed ID: 6437010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immune coagulation disorders (excluding antiphospholipid syndrome].
    Arai M
    Rinsho Byori; 2001 Oct; 49(10):1000-4. PubMed ID: 11769464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epitope specificity of anti-factor VIII antibodies from inhibitor positive acquired and congenital haemophilia A patients using synthetic peptides spanning A and C domains.
    Gharagozlou S; Sharifian RA; Khoshnoodi J; Karimi K; Milani M; Okita DK; Shokri F; Conti-Fine BM
    Thromb Haemost; 2009 May; 101(5):834-9. PubMed ID: 19404535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of porcine factor VIII for surgical procedures in hemophilia A patients with inhibitors.
    Lozier JN; Santagostino E; Kasper CK; Teitel JM; Hay CR
    Semin Hematol; 1993 Apr; 30(2 Suppl 1):10-21. PubMed ID: 8480192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solid tumors and factor VIII antibodies.
    Hauser I; Lechner K
    Thromb Haemost; 1999 Sep; 82(3):1005-7. PubMed ID: 10494753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactivity profile of anti-factor VIII antibodies with designed synthetic peptides mimicking epitopes of the C2 and a1 domains.
    Chaves DG; Velloso-Rodrigues C; Moreau V; Nguyen C; Villard S; Belisário AR; Granier C; Santoro MM
    Br J Haematol; 2008 May; 141(5):708-15. PubMed ID: 18422780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppression of patients with acquired factor VIII inhibitors.
    Green D
    Semin Hematol; 1994 Apr; 31(2 Suppl 4):60-1. PubMed ID: 7939780
    [No Abstract]   [Full Text] [Related]  

  • 14. Factor VIII inhibitors--an algorithmic approach to treatment.
    Kessler CM
    Semin Hematol; 1994 Apr; 31(2 Suppl 4):33-6. PubMed ID: 7939771
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of plasma antibody epitopes and gene abnormalities in Japanese hemophilia A patients with factor VIII inhibitor.
    Sugihara T; Takahashi I; Kojima T; Okamoto Y; Yamamoto K; Kamiya T; Matsushita T; Saito H
    Nagoya J Med Sci; 2000 May; 63(1-2):25-39. PubMed ID: 10911718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerance to factor VIII inhibitors in hemophilia A patients: a French twist.
    Pascual V; Capra JD
    J Clin Invest; 1996 Mar; 97(6):1357-8. PubMed ID: 8617864
    [No Abstract]   [Full Text] [Related]  

  • 17. Acquired hemophilia: a case report of 2 patients with acquired factor VIII inhibitor treated with rituximab plus a short course of steroid and review of the literature.
    Alvarado Y; Yao X; Jumper C; Hardwicke F; D'Cunha N; Cobos E
    Clin Appl Thromb Hemost; 2007 Oct; 13(4):443-8. PubMed ID: 17911199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dominant C2 domain epitope specificity of inhibitor antibodies elicited by a heat pasteurized product, factor VIII CPS-P, in previously treated hemophilia A patients without inhibitors.
    Sawamoto Y; Prescott R; Zhong D; Saenko EL; Mauser-Bunschoten E; Peerlinck K; van den Berg M; Scandella D
    Thromb Haemost; 1998 Jan; 79(1):62-8. PubMed ID: 9459325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acquired autoantibodies against human factor VIII: a new case].
    Cailleux N; Levesque H; Courtois H; Borg JY
    J Mal Vasc; 1996; 21(5):324-8. PubMed ID: 9026552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunosuppressive treatment of a spontaneous inhibitor hemophilia A using cyclophosphamide, vincristine and prednisone following prior Factor VIII stimulation].
    Dürig J; de Wit M; Fiedler W; Marx G; Hossfeld DK
    Schweiz Med Wochenschr; 1996 Nov; 126(47):2026-31. PubMed ID: 8984611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.